Preliminary study analysis suggests similar efficacy for didanosine and zalcitabine.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D016049:Didanosine / Q000627:therapeutic use*; D006801:Humans; D016896:Treatment Outcome; D016047:Zalcitabine / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine